These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22292622)

  • 1. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
    Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
    Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.
    Wang HG; Wu QY; Zhou H; Peng XS; Shi MJ; Li JM; Zhou YF
    Asian Pac J Cancer Prev; 2014; 15(13):5277-81. PubMed ID: 25040988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.
    Ma YY; Guan TP; Yao HB; Yu S; Chen LG; Xia YJ; He XJ; Wang HJ; Jiang XT; Tao HQ
    PLoS One; 2013; 8(1):e55019. PubMed ID: 23383041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
    Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
    PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.
    Zhuo X; Ye H; Li Q; Xiang Z; Zhang X
    Medicine (Baltimore); 2016 Mar; 95(9):e2948. PubMed ID: 26945408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis.
    Fang F; Yu XJ; Yu L; Yao L
    Med Oncol; 2011 Dec; 28(4):981-5. PubMed ID: 20503107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis.
    Liu G; Jiang D; Shen S; Yu L
    Int J Urol; 2012 Oct; 19(10):914-20. PubMed ID: 22716509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.
    Zhang Y; Bai Y; Zhang Y; Guan J; Chen L
    Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Mouse Double Minute 2 -309T>G Polymorphism with Acute Myeloid Leukemia in an Iranian Population: A Case- Control Study.
    Soleymannejad M; Sheikhha MH; Neamatzadeh H
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3037-3041. PubMed ID: 31653152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Mo C; Qin A; Lao X; Chen Z; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    J Exp Clin Cancer Res; 2013 Nov; 32(1):85. PubMed ID: 24423195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of MDM2-309 polymorphisms and induced corresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinoma.
    Zhou J; Liu F; Zhang D; Chen B; Li Q; Zhou L; Lu LM; Tao L
    DNA Cell Biol; 2014 Feb; 33(2):88-94. PubMed ID: 24325471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma.
    Nakashima M; Kondo S; Shimizu Y; Wakisaka N; Murono S; Furukawa M; Yoshizaki T
    Acta Otolaryngol; 2008 Jul; 128(7):808-13. PubMed ID: 18568525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck.
    Yu H; Huang YJ; Liu Z; Wang LE; Li G; Sturgis EM; Johnson DG; Wei Q
    Mol Carcinog; 2011 Sep; 50(9):697-706. PubMed ID: 21656578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.
    Ma HB; Huang T; Han F; Chen WY
    Asian Pac J Cancer Prev; 2012; 13(6):2841-6. PubMed ID: 22938470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
    Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
    Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic polymorphism in MDM2 is associated with susceptibility to colorectal cancer in a Chinese population].
    Liu JN; Zhang XM; Guo YL; Sun T; Lin DX; Wen T
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):335-8. PubMed ID: 18953830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.